J J. Nair, J van Staden, J Bastida - Current medicinal chemistry, 2016 - benthamdirect.com
The Amaryllidaceae occupies a privileged status amongst medicinal plants in having delivered the Alzheimer's drug galanthamine to the clinical market. Following its resounding …
The redeployed drug combination of bezafibrate and medroxyprogesterone acetate (designated BaP) has potent in vivo anticancer activity in acute myelogenous leukemia …
M Masoodi, M Eiden, A Koulman, D Spaner… - Analytical …, 2010 - ACS Publications
In the present work we describe the development of an analytical technique for simultaneous profiling of over 100 biochemically related lipid mediators in biological …
Background The majority of acute myeloid leukaemia (AML) patients are over sixty years of age. With current treatment regimens, survival rates amongst these, and also those younger …
EM Youssef-Elabd, KC McGee, G Tripathi… - The Journal of nutritional …, 2012 - Elsevier
A post-prandial increase in saturated fatty acids (SFAs) and glucose (Glc) activates an inflammatory response, which may be prolonged following restoration of physiological SFAs …
Background Over recent years, enzymes of the aldo-keto reductase (AKR) 1C subfamily have been implicated in the progression of prostate, breast, endometrial and leukemic …
E Novotná, N Büküm, J Hofman, M Flaxová… - Archives of …, 2018 - Springer
Dinaciclib is a multi-specific cyclin-dependent kinase (CDK) inhibitor with significant preclinical and clinical activity. It inhibits CDK1, CDK2, CDK5, CDK9 and CDK12 in the …
Gene–environment interactions influence an individual's risk of disease development. A common human 8-oxoguanine DNA glycosylase 1 (OGG1) variant, Cys326-hOGG1, has …
FX Ruiz, S Porté, O Gallego, A Moro… - Biochemical …, 2011 - portlandpress.com
Human AKR (aldo–keto reductase) 1C proteins (AKR1C1–AKR1C4) exhibit relevant activity with steroids, regulating hormone signalling at the pre-receptor level. In the present study …